Silve Spring, Maryland–(ENEWSPF)–March 14, 2012. The U.S. Food and Drug Administration today approved the first generic Lexapro (escitalopram tablets) to treat both depression and generalized anxiety disorder in adults.
Depression is characterized by symptoms that interfere with a person’s ability to work, sleep, study, eat, and enjoy once-pleasurable activities. Episodes of depression often recur throughout a person’s lifetime.
Signs and symptoms of major depression include: depressed mood, loss of interest in usual activities, significant change…
